Frost, A., Mross, K., Steinbild, S., Hedbom, S., Unger, C., Kaiser, R., . . . Munzert, G. (2012). Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours. Multimed Inc.

Frost, A., K. Mross, S. Steinbild, S. Hedbom, C. Unger, R. Kaiser, D. Trommeshauser, ja G. Munzert. Phase I Study of the Plk1 Inhibitor BI 2536 Administered Intravenously On Three Consecutive Days in Advanced Solid Tumours. Multimed Inc, 2012.

Frost, A., et al. Phase I Study of the Plk1 Inhibitor BI 2536 Administered Intravenously On Three Consecutive Days in Advanced Solid Tumours. Multimed Inc, 2012.